Hani Abouhalka, MBA

Company Group Chairman, Medical Devices EMEA, Johnson & Johnson, New Brunswick, NJ, USA

Anne-Sophie Bricca

Deputy General Counsel & Senior Director Legal Affairs & Compliance, Terumo BCT Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ETHICS); Chair, Ethics and Compliance Group MedTech Europe, Brussels, Belgium

Stephen Nguyen Duc

Vice-President, Global Head of Human Resources and Ethics & Compliance, Medday Pharmaceuticals; Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Dominique Laymand, Esq.

Executive Vice President, Chief Ethics and Social Responsibility Officer, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst

EMEA Lead, Third Party Intermediary, Ethics & Compliance, Johnson & Johnson; President, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS); Chairman, MedTech Europe Code Committee, Brussels, Belgium

N. Craig Smith

Chaired Professor of Ethics and Social Responsibility, Academic Director of ESRI (the INSEAD Ethics and Social Responsibility Initiative), and Programme Director for the Healthcare Compliance Implementation Leadership Programme, INSEAD Fontainebleau, France (Discussion Coordinator)

Adam Dubow, JD

Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Princeton, NJ, USA

Mwana Lugogo, JD, MPP

Chief Ethics and Compliance Officer, Takeda Pharmaceuticals International GmBh, Zurich, Switzerland

Pascale Schmidt

Chief Compliance Officer and Chair, Corporate Sustainability Committee, F. Hoffmann-La Roche Ltd, Basel, Switzerland

Trudy Tan

Global Head Ethics, Risk & Compliance, Pharma, Novartis; Former Vice President Compliance, International, AstraZeneca, Basel, Switzerland

Mariusz Witalis

Partner, Forensic & Integrity Services, EY, Warsaw, Poland (Discussion Coordinator)

AFTERNOON MINI SUMMITS

MINI SUMMITS ROUND I

MINI SUMMIT 1: Ethics and Compliance Considerations for Small to Mid-sized Organizations

2:30 pm

Introductions, Panel Discussion and Q&A

Kalwant Dhindsa, CIPP/E, CCEP

Compliance Director, Convatec; Former Senior Corporate Compliance Counsel, Bayer, Reading, UK

Rosa Magistri, CIPP/E

Head of Legal and Compliance Europe, SeaGen International GmbH; Former Regional Director Office of Ethics and Compliance, Western Europe & Canada, Region South & Israel, AbbVie; Former Associate Compliance Director, Shire, Zug, Switzerland

Chrisoula Nikidis, LL.L.

Head of Ethics and Compliance, Takeda Canada; Former Vice President, Ethics, Integrity, & Governance, Innovative Medicines Canada, Toronto, Canada

Madina Torchinova, JD

Vice President, Head Global Compliance, MorphoSys; Former Regional Head of Compliance, Central & Eastern Europe, Middle East & Africa, and Global OTC, Sandoz, Munich, Germany

Mario Prohasky

Principal, EMEA Compliance Consulting Lead, IQVIA, London, UK (Discussion Coordinator)

MINI SUMMIT 2: Annual Medical Device Compliance Roundtable

2:30 pm

Introductions, Panel Discussion and Q&A

Aline Lautenberg, LLM

General Counsel, Director Legal & Compliance, MedTech Europe, Brussels, Belgium

Laetitia Thevenon

Compliance and External Collaboration Manager EMEA, ResMed; Former Chair, Compliance Committee, SNITEM, Lyon, France

Nancy S. Travis, MS

Vice President, Global Compliance and Governance, Advanced Medical Technology Association (ADvaMed), Washington, DC, USA

Roeland Van Aelst

EMEA Lead, Third Party Intermediary, Ethics & Compliance, Johnson & Johnson; President, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS); Chairman, MedTech Europe Code Committee, Brussels, Belgium

Fabien Roy

Partner, Hogan Lovells, Brussels, Belgium (Discussion Coordinator)

MINI SUMMIT 3: Best Practices for Ethics and Compliance Training

2:30 pm

Introductions, Panel Discussion and Q&A

Signe Elbæk, JD, LLM

Visitor Researcher, Faculty of Law, University of Copenhagen; Former Group Chief Compliance Officer, Coloplast; Former Vice Chair, Ethics and Compliance Committee and Member of the Code Committee, MedTech Europe; Former Compliance Manager, Attorney, Dako Denmark A/S; Copenhagen, Denmark

Nicola Giovinazzi, EMBA

Corporate Compliance Director, Menarini Group; Former Compliance and Ethics Lead Italy, Switzerland, and Austria, Bristol-Myers Squibb, Florence, Italy

Bella Rafael Hovhannisyan

Chief Ethics & Compliance Officer, CSL Group; Former Compliance & Ethics Lead, Spain & Portugal, Russia & Turkey, Bristol-Myers Squibb; Berne, Switzerland

Nadège Rochel, CCEP-I

Global Compliance Manager, Hollister Incorporated, Milan, Italy

Robert Stephenson

Director, PwC UK, London, UK (Discussion Coordinator)

MINI SUMMIT 4: Analytics and Behavioral Science in Successful Compliance Programs

2:30 pm

Introductions, Panel Discussion and Q&A

Amanda Bunten, DPsych

Chartered Health Psychologist; Director of Behavioral Ethics, GlaxoSmithKline;Former Principal Behavioural Insights Advisor,Public Health England, London, UK

Caitlin Handron, PhD

Senior Lab Consultant and Behavioral Scientist, R&G Insights Lab, Ropes & Gray LLP, Silicon Valley, CA

Tara Palesh, MS

Senior Director, Compliance Analytics Lead, Pfizer, New York, NY, USA

Sapan Singh, MBA

Senior Director Compliance, Stryker Corporation, Mahwah, NJ, USA

Zachary N. Coseglia, JD

Managing Principal and Head of Innovation, R&G Insights Lab, Ropes & Gray, LLP, Boston, MA, USA (Co-Discussion Coordinator)

MINI SUMMIT 5: Annual Central and Eastern Europe (CEE) Compliance Best Practices Update

2:30 pm

Introductions, Panel Discussion and Q&A

Chelsea M. Keeton, JD

Director and Senior Counsel, Global Compliance Investigations, Zimmer Biomet; Former Group Ethics & Compliance Counsel, VEON, Amsterdam, Netherlands

Tomasz Kruk, LLM, MBA

Head of Compliance, Vifor Pharma; Former Director International Compliance, Mallinckrodt; Former Director Global Ethics & Compliance, Actavis, Zürich, Switzerland

Leonardo Silva, LLM

Vice President, Global Chief Compliance & Privacy Officer, Ferring Pharmaceuticals; Former Head of Compliance, Acino Group, Acino International AG; Former Compliance Director, Emerging Markets, Takeda, Lausanne, Switzerland

Paul J. Melling, JD

Founding Partner, Baker & McKenzie, CIS, Limited, Moscow, Russia (Co-Discussion Coordinator)

Mariusz Witalis

Partner, Forensic & Integrity Services, EY, Warsaw, Poland (Co-Discussion Coordinator)

Topic I: Practical Ways to Apply Behavioral Science to Foster Compliance Programs and Culture

Eric J. Bottelier

Director, Ethics, Risk & Compliance, US Oncology, Novartis Pharmaceuticals Corporation; Former NA Compliance & Business Ethics, Sanofi, Erwinna, Pennsylvania (Discussion Coordinator)

Michael L. Shaw, JD

Principal, Global Head of Risk & Compliance, ZS; Former Vice President & Compliance Officer - Global Therapy Areas & U.S. Pharma, GSK, Philadelphia, PA (Discussion Coordinator)

Topic II: Compliance Risk Assessment Integrating Legal and Cultural Requirements

Peter Dieners, Esq.

Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance; Member, Legal Affairs Focus Group and Compliance Network, MedTech Europe; Member, Legal Affairs Committee and Healthcare Compliance Committee, BVMed, Düsseldorf, Germany (Discussion Coordinator)

David Rodin, PhD

Founder and Chief Executive Officer, Principia Advisory, Former Co-Director, Institute for Ethics, Law, and Armed Conflict, Oxford University, Trélex, Vaud, Switzerland (Discussion Coordinator)

Topic III: Why Friction between Compliance and the Business Is Good for Everyone

Michaela Ahlberg, LLM, CCEP, CCEP-I

Senior Advisor, Getinge; Ethics & Compliance and Anti Bribery Corruption Specialist, TheGreyZone, Göteborgsområdet, Sweden (Discussion Coordinator)

Richard Bistrong, MA

Chief Executive Officer, Front-Line Anti-Bribery, LLC; Contributing Editor, FCPA Blog; Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ; Former Cooperating Witness, City of London Police, HMRC and CPS, UK New York, NY, USA (Discussion Coordinator)

Topic IV: Best Practices Implementing Equity, Diversity & Inclusion into Ethics and Compliance Programs

Evelyne Lemaire, MA

Vice President, Head of Ethics & Compliance Global Manufacturing & Supply and Global Quality, Takeda, Zurich, Switzerland (Discussion Coordinator)

Michael R. Clarke, JD, CCEP

Vice President, Global Chief Compliance Officer, ConvaTec; Former Vice President, Corporate Compliance, Indivior; Former Vice President, Ethics & Compliance, Americas, Actavis; Bridgewater, NJ, USA (Discussion Coordinator)

Kishwar Chishty, ACA

Partner Risk Advisory Life Sciences, Deloitte Switzerland, Basel, Switzerland (Discussion Coordinator)

Trudy Tan

Global Head Ethics, Risk & Compliance, Pharma, Novartis; Former Vice President Compliance, International, AstraZeneca, Basel, Switzerland (Discussion Coordinator)